The Last Decade of Medicinal Plant Genomics: Advances and Challenges
Junfeng Chen , Yuchen Zhang , Yajing Li , Yiru Liu , Qing Li , Zongyou Lv , Milen I. Georgiev , Pan Liao
Engineering ››
The Last Decade of Medicinal Plant Genomics: Advances and Challenges
Over the past decade (2014–2025), owing to increasing genome sequencing technologies and decreasing cost, research on medicinal plant genomes (MPGs) has expanded extensively. This advancement has significantly accelerated progress in multiple areas, including elucidating specialized metabolic pathways, conserving endangered species, advancing molecular breeding strategies, and accelerating metabolic engineering innovations. Here, we attempt to provide a contemporary view of MPGs, including analyses of sequenced species and assembly data, the advantages of illustrating the metabolic pathways of active compounds, and demonstrating how MPGs facilitate the metabolic biosynthesis characterization of medicinal plants.
Medicinal plant / Genome sequencing / Active metabolites / Biosynthesis pathway / Multiomics
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
/
| 〈 |
|
〉 |